[Combined radiotherapy and hormone therapy in non-metastatic adenocarcinoma of prostate].
Non-metastatic adenocarcinoma of prostate can be cured in the vast majority of cases with surgery and/or external or interstitial radiotherapy. Failures are much more frequent when tumors are locally advanced. For this reason, new strategies have been designed, among them combined radiotherapy and hormone therapy, in most cases with a LHRH analog, neoadjuvant and/or concomitant and/or adjuvent. Analysis of results of recent randomised trials comparing this association and exclusive radiotherapy allows for validating concept of combined radiotherapy and hormone therapy in locally advanced adenocarcinoma of prostate, while many questions should be more clearly answered.
Lopez
S
S
Service de radiothérapie oncologique, groupe hospitalier de La Pitié-Salpêtrière, AP-HP, Paris, France.
Simon
J-M
JM
Mazeron
J-J
JJ